statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

I-Mab Announces Leadership Transitions

I-Mab Announces Leadership Transitions I-Mab Announces Leadership Transitions PR Newswire ROCKVILLE, Md., July 15, 2024 ROCKVILLE, Md., July 15, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the...

I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer

I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer PR Newswire ROCKVILLE, Md., June 6, 2024 ROCKVILLE, Md., June 6, 2024...

I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers

I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers I-Mab Announces Collaboration with Bristol...

I-Mab to Participate at the Jefferies Global Healthcare Conference

I-Mab to Participate at the Jefferies Global Healthcare Conference I-Mab to Participate at the Jefferies Global Healthcare Conference PR Newswire ROCKVILLE, Md., May 22, 2024 ROCKVILLE, Md., May 22...

(IMAB) - Analyzing I-MAB's Short Interest

I-MAB Filed 2023 Annual Report on Form 20-F

I-MAB Filed 2023 Annual Report on Form 20-F I-MAB Filed 2023 Annual Report on Form 20-F PR Newswire ROCKVILLE, Md., April 30, 2024 ROCKVILLE, Md., April 30, 2024 /PRNewswire/ --I-Mab (the 'Company...

I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference

I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference PR Newswire ROCKVILLE, Md., April 5, 2024...

I-Mab Announces Closing of the Divestiture of Business Operations in China

I-Mab Announces Closing of the Divestiture of Business Operations in China I-Mab Announces Closing of the Divestiture of Business Operations in China PR Newswire ROCKVILLE, Md., April 2, 2024...

I-Mab price target lowered by $5 at Piper Sandler, here's why

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

I-Mab price target lowered by $10 at H.C. Wainwright, here's why

I-Mab operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Rockville, MD.

Volume	300,488.00
52-Wk High	$2.96
52-Wk Low	$1.16

IMAB I-Mab - ADR

About

Feed

News

Sentiment

Earnings

Fundamentals